Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

CSE Bulletin: MOC Eligibility Update

October 18, 2025

Harvest Gold Provides Update on its Ongoing Drill...

September 26, 2025

Nevada Sunrise Metals

November 28, 2025

Lithium Universe LtdCompletes PV Solar Cell Recycling Acquisition

July 18, 2025

Investor Presentation Scandinavian Copper-Gold Project

November 28, 2025

Greenland Lithium Pegmatite Field Significantly Expanded by Brunswick...

August 13, 2025

Newmont to Exit Toronto Stock Exchange as Cost...

September 12, 2025

Tech Weekly: CES Announcements Reignite Memory Shortage Concerns

January 11, 2026

How Would a New BRICS Currency Affect the...

November 26, 2025

Altech Batteries LtdBoard Renewal and Strategic Focus

December 1, 2025